- Adagio Medical reported publication of pre-clinical results for its next-generation ultra-low temperature ablation catheter designed for ventricular arrhythmias in the Journal of Cardiovascular Electrophysiology.
- The paper described functional changes versus the first-generation vCLAS ULTA catheter, including a potential 50-75% reduction in ablation time.
- In pre-clinical models, the technology achieved ablation temperatures of about -170°C and produced 5-millimeter lesions in 15 seconds.
- The publication also reported 12.5-millimeter lesions in about 120 seconds.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adagio Medical Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260324055565) on March 24, 2026, and is solely responsible for the information contained therein.
Comments